Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription 25.08.2025 1 Arch Pediatr 1 Arch Virol 3 BMJ 1 Clin Infect Dis 4 J Infect 4 J Infect Dis 2 J Pediatr 6 J Virol 2 JAMA 1 MMWR Morb Mortal Wkly Rep 1 Nat Med 4 Pediatr Infect Dis J 1 Pediatrics 1 PLoS Comput Biol 2 PLoS One 1 Proc Natl Acad Sci U S A 34 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Pediatr

1. VAROQUI C, Thollot F
   Traveling children: Current situation and compliance with hepatitis A vaccination recommendations.
   Arch Pediatr. 2025 Aug 14:363-367. doi: 10.1016/j.arcped.2025.
   PubMed         Abstract available
   
   

   
   Arch Virol

2. ZADEH MEHRIZI T, Eshrati B, Ebrahimi Shahmabadi H
   Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness across WHO regions with HBV prevalence above 1% in the general population up to 60 years of age: a systematic review.
   Arch Virol. 2025;170:193.
   PubMed        
   
   

   
   BMJ

3. TANNE JH
   US paediatrician group opposes RFK Jr by recommending covid vaccines for children.
   BMJ. 2025;390:r1790.
   PubMed        
   
   
4. O'DOWD A
   Conflicts of interest were at record low when RFK Jr dismissed "conflicted" vaccine panel.
   BMJ. 2025;390:r1774.
   PubMed        
   
   
5. TANNE JH
   Leading US journal refuses RFK Jr's request to retract childhood vaccine study.
   BMJ. 2025;390:r1765.
   PubMed        
   
   

   
   Clin Infect Dis

6. REZAHOSSEINI O, Staehr Jensen JU, Rahimi HK, Jensen NE, et al
   Immunogenicity and Safety of the COVID-19 mRNA Vaccine Coadministered with Influenza and 23-valent Pneumococcal Polysaccharide Vaccines.
   Clin Infect Dis. 2025 Aug 18:ciaf455. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect

7. TILEY KS, Ten Hulscher-van Overbeek H, Basnet S, van Binnendijk R, et al
   The waning of maternal measles antibodies: A multi-country maternal-infant seroprevalence study.
   J Infect. 2025;91:106531.
   PubMed         Abstract available
   
   
8. MCGEOCH LJ, Foulkes S, Whitaker H, Munro K, et al
   Effectiveness of influenza vaccination against infection in UK healthcare workers during winter 2023-24: The SIREN cohort study.
   J Infect. 2025;91:106585.
   PubMed         Abstract available
   
   
9. AHIMBISIBWE G, Greenwood D, Wilkinson KA, Gahir J, et al
   Third exposure to COVID-19 infection or vaccination differentially impacts T Cell responses.
   J Infect. 2025 Aug 21:106598. doi: 10.1016/j.jinf.2025.106598.
   PubMed         Abstract available
   
   
10. LIU B, Song S, Liu W, Hu Y, et al
    Post-COVID-19 multimorbidity incidence by prior vaccination status in people with a pre-existing comorbidity: A population-based cohort study.
    J Infect. 2025;91:106597.
    PubMed         Abstract available
    
    

    
    J Infect Dis

11. SCULLY EP, Morgan R, Klein SL
    Precision Vaccinology: Making Vaccines Work Better for Women and Men.
    J Infect Dis. 2025 Aug 20:jiaf397. doi: 10.1093.
    PubMed         Abstract available
    
    
12. FRIEDMAN-KLABANOFF DJ, Jensen TL, Gelber CE, Pinapati RS, et al
    Vaccine-induced antibodies to a C-terminal Plasmodium falciparum circumsporozoite protein epitope are associated with protection.
    J Infect Dis. 2025 Aug 19:jiaf391. doi: 10.1093.
    PubMed         Abstract available
    
    
13. ONG DS, von Mollendorf C, Mulholland K, Do LAH, et al
    Measles Seroprevalence in Infants Under 9 Months of Age in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    J Infect Dis. 2025;232:316-326.
    PubMed         Abstract available
    
    
14. WOLFE C, Ionescu IG, Mayrand MH, Coutlee F, et al
    Prevalence of Human Papillomavirus Genotypes in Unvaccinated 16- to 20-Year-Old Men in Quebec, Canada.
    J Infect Dis. 2025;232:e203-e212.
    PubMed         Abstract available
    
    

    
    J Pediatr

15. ANDERSEN KM, McColgan MD, Mateus JS, Yu T, et al
    BNT162b2 XBB.1.5-Adapted Single Dose Vaccine Uptake and Effectiveness in Children Aged 5-17 Years in California and Louisiana.
    J Pediatr. 2025 Aug 14:114778. doi: 10.1016/j.jpeds.2025.114778.
    PubMed         Abstract available
    
    
16. TOP KA, Bettinger JA, Embree JE, Jadavji T, et al
    Active Surveillance for Myocarditis and Pericarditis in Canadian Children from 2021 to 2022: A Canadian Immunization Monitoring Program ACTive Study.
    J Pediatr. 2025;284:114642.
    PubMed         Abstract available
    
    

    
    J Virol

17. CHIU H-J, Wang H-C, Chang W
    Structural dissection of vaccinia G9 identifies residues essential for membrane fusion and complex assembly.
    J Virol. 2025 Aug 18:e0072325. doi: 10.1128/jvi.00723.
    PubMed         Abstract available
    
    
18. HU J, Zheng H, Ran W, Wang X, et al
    Mucosal vaccination with long-form TSLP induces migratory cDC1-mediated adaptive immunity against SARS-CoV-2 infection.
    J Virol. 2025 Aug 19:e0123125. doi: 10.1128/jvi.01231.
    PubMed         Abstract available
    
    
19. ZHANG H, Deng X, Dai R, Fu J, et al
    Inadequate immune response to inactivated COVID-19 vaccine among older people living with HIV: a prospective cohort study.
    J Virol. 2025 Aug 21:e0068825. doi: 10.1128/jvi.00688.
    PubMed         Abstract available
    
    
20. LIU J, Xia Y, Tian C, Chen Z, et al
    E2-based mRNA vaccine encapsulated in lipid nanoparticles protects pigs against classical swine fever virus.
    J Virol. 2025 Aug 21:e0097825. doi: 10.1128/jvi.00978.
    PubMed         Abstract available
    
    
21. HE Q, Zou Y, Yu B, Yuan Q, et al
    A novel nanoparticle vaccine, based on S1-CTD, elicits robust protective immune responses against porcine deltacoronavirus.
    J Virol. 2025 Aug 21:e0067425. doi: 10.1128/jvi.00674.
    PubMed         Abstract available
    
    
22. HU Z, Tian S, Zhou Y, Wang Y, et al
    Nanoparticle vaccine based on the pre-fusion F glycoprotein of respiratory syncytial virus elicits robust protective immune responses.
    J Virol. 2025 Aug 26:e0090325. doi: 10.1128/jvi.00903.
    PubMed         Abstract available
    
    

    
    JAMA

23. KANTER GP, Mankowitz T, Lurie P
    Conflicts of Interest in Federal Vaccine Advisory Committees.
    JAMA. 2025 Aug 18:e2513245. doi: 10.1001/jama.2025.13245.
    PubMed        
    
    
24. ANDERER S
    COVID-19 Vaccines Averted 2.5 Million Deaths, Mostly Among Older Adults.
    JAMA. 2025 Aug 15. doi: 10.1001/jama.2025.11001.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

25. BOUNDY EO, Fast H, Jatlaoui TC, Razzaghi H, et al
    Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:484-489.
    PubMed         Abstract available
    
    

    
    Nat Med

26. SHORE ND, Powles TB, Bedke J, Galsky MD, et al
    Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial.
    Nat Med. 2025 May 31. doi: 10.1038/s41591-025-03738.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

27. MA P, Chen PD, Jadhav S, He LL, et al
    Longitudinal Antibody Responses to SARS-CoV-2 Infection in Children: Impact of Age, Vaccines and Symptoms.
    Pediatr Infect Dis J. 2025 Aug 26. doi: 10.1097/INF.0000000000004949.
    PubMed         Abstract available
    
    
28. PICHON S, Ullery GM, Cousin L, Sadarangani M, et al
    Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants.
    Pediatr Infect Dis J. 2025 Aug 15. doi: 10.1097/INF.0000000000004913.
    PubMed         Abstract available
    
    
29. LUAN G, Zhang W, Cheng Y, Liu Y, et al
    Temporal Trends and Regional Disparities in Rotavirus Vaccine Coverage for Children Under 1-Year-old in Shandong Province, China.
    Pediatr Infect Dis J. 2025 Aug 13. doi: 10.1097/INF.0000000000004953.
    PubMed         Abstract available
    
    
30. LOEVE LF, Sideridou VL, Scholvinck EH, Brandsema RB, et al
    A CASE OF CONGENITAL RUBELLA SYNDROME IN THE NETHERLANDS: A Brief Report on Rubella Virus Surveillance.
    Pediatr Infect Dis J. 2025 May 21. doi: 10.1097/INF.0000000000004849.
    PubMed         Abstract available
    
    

    
    Pediatrics

31. 
    Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents: Policy Statement.
    Pediatrics. 2025 Aug 19. doi: 10.1542/peds.2025-073924.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

32. TORRES-FLOREZ S, Flores Anato JL, He JH, Portilla VG, et al
    Evaluating COVID-19 vaccination policy in Quebec (Canada) using a data-driven dynamic transmission model.
    PLoS Comput Biol. 2025;21:e1013207.
    PubMed         Abstract available
    
    

    
    PLoS One

33. LEONHARD AK, Badre-Esfahani SK, Larsen MB, Petersen LK, et al
    "Two shots for life. HPV-vaccination at your school". Co-creation of a complex intervention to reduce ethnic inequity in childhood HPV-vaccination in Denmark.
    PLoS One. 2025;20:e0323870.
    PubMed         Abstract available
    
    
34. LEUNG T, Ferrari M
    Bias in the estimated reporting fraction due to vaccination in the time-series SIR model.
    PLoS One. 2025;20:e0330568.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

35. WANG S, Sun H, Wang Y, Wang Z, et al
    Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variants.
    Proc Natl Acad Sci U S A. 2025;122:e2503254122.
    PubMed         Abstract available
    
    

    
    Vaccine

36. KOCER AT, Durasi E, Kuscu E, Amasya H, et al
    Piercing the future of vaccination: the revolutionary role of microneedle-based systems in healthcare advancements.
    Vaccine. 2025;63:127612.
    PubMed         Abstract available
    
    
37. MORSTEAD T, Loo N, Sin NL, DeLongis A, et al
    COVID-19 hoax belief endorsement and its implications for vaccine uptake: Investigating the role of perceived threat.
    Vaccine. 2025;63:127630.
    PubMed         Abstract available
    
    
38. ALBERS AN, Fox ER, Michels SY, Daley MF, et al
    Late initiation of pneumococcal and Haemophilus influenzae type b vaccinations.
    Vaccine. 2025;62:127611.
    PubMed         Abstract available
    
    
39. BUHL C, Jacobsen R, Traulsen JM, Andersen A, et al
    Validation of the Danish translation of the vaccination attitudes examination (VAX) scale.
    Vaccine. 2025;62:127620.
    PubMed         Abstract available
    
    
40. VARISKALLIO S, Moustgaard H, Remes H, Martikainen P, et al
    Association of parental education with adolescents' COVID-19 vaccine uptake: A nationwide register-based study in Finland.
    Vaccine. 2025;63:127615.
    PubMed         Abstract available
    
    
41. JEONG NY, Cho S, Lim E, Lee JR, et al
    COVID-19 vaccination and the risk of abnormal uterine bleeding: A nationwide self-controlled case series study.
    Vaccine. 2025;63:127619.
    PubMed         Abstract available
    
    
42. LANKIEWICZ E, Mpemba JKN, Dikassa PSL, Masiala VM, et al
    Trends in vaccination coverage and equity in the Democratic Republic of the Congo from 2017 to 2023.
    Vaccine. 2025;62:127609.
    PubMed         Abstract available
    
    
43. ROEL E, Henderson E, Valmayor S, Porthe V, et al
    Effectiveness of CONFIVAC, an intervention to enhance paediatric nurses and paediatricians skills to promote vaccination: A mixed-methods cluster randomized trial.
    Vaccine. 2025;62:127603.
    PubMed         Abstract available
    
    
44. GIACANI L, Romeis E, Haynes A, Molini BJ, et al
    Immunization with full-length TprC variants induces a broad response to surface-exposed epitopes of the Treponema pallidum repeat protein family and is partially protective in the rabbit model of syphilis.
    Vaccine. 2025;61:127406.
    PubMed         Abstract available
    
    
45. KORHONEN MJ, Polkki M, Anttila VJ, Klemets P, et al
    Healthcare resource use and costs associated with episodes of laboratory confirmed invasive pneumococcal disease in adults in Finland 2016-2022.
    Vaccine. 2025;61:127398.
    PubMed         Abstract available
    
    
46. ZHOU L, Yang Y, Mo C, Zhu Y, et al
    Human adenovirus penton dodecahedron nanoparticles induce an enhanced neutralizing antibody response in mouse model.
    Vaccine. 2025;61:127380.
    PubMed         Abstract available
    
    
47. MARQUEZ AC, Beitari S, Valadbeigy T, Sbihi H, et al
    COVID-19 serological survey utilizing antenatal serum samples in British Columbia.
    Vaccine. 2025;61:127310.
    PubMed         Abstract available
    
    
48. KURTZ SL, Gould V, Flores-Valdez MA, Elkins KL, et al
    Recombinant BCGDeltaBCG1419c protects outbred mice against M. tuberculosis challenge.
    Vaccine. 2025;61:127347.
    PubMed         Abstract available
    
    
49. KASSAM P, Laurie C, El-Zein M, Tota JE, et al
    Impact of HPV vaccination on the incidence and clearance of HPV infections in sexually active young women.
    Vaccine. 2025;63:127632.
    PubMed         Abstract available
    
    
50. MARTORELL S, Ligda P, Rai S, Alward L, et al
    Efficacy of a candidate vaccine against Leishmania infantum on naturally exposed dogs to sand flies.
    Vaccine. 2025;63:127646.
    PubMed         Abstract available
    
    
51. GROOM HC, Kuntz JL, Varga AM, Smith N, et al
    Parental intent to vaccinate children with the updated 2023-2024 COVID-19 vaccine.
    Vaccine. 2025;63:127618.
    PubMed         Abstract available
    
    
52. MCDANIELS-DAVIDSON C, Parada H Jr, Martinez ME, Martinez LS, et al
    Validation of a parent HPV vaccine misperceptions scale and its association with children's HPV vaccination status.
    Vaccine. 2025;63:127616.
    PubMed         Abstract available
    
    
53. CIESLA AA, Mak J, Godoshian A, Smith ZR, et al
    Symptom reporting and vaccination status among SARS-CoV-2-positive encounters - Increasing Community Access to Testing, Treatment, and Response program, United States, September 2023-August 2024.
    Vaccine. 2025;63:127635.
    PubMed         Abstract available
    
    
54. JEFFERS A, Kuiper NM, Ramakrishnan A, Swarna H, et al
    Building trust in community-academic partnerships: Strategies for enhancing vaccine confidence and demand - Lessons from Prevention Research Centers.
    Vaccine. 2025;60 Suppl 1:127624.
    PubMed         Abstract available
    
    
55. DE SOUZA KSS, Lopes JM, Ribeiro RMR, Lescano CH, et al
    Genetic and molecular basis for low efficacy of vaccine strains against canine distemper virus in Brazil.
    Vaccine. 2025;62:127621.
    PubMed         Abstract available
    
    
56. BRUCKER A, Hurst JH, O'Brien EC, Anderson D, et al
    An analytic approach considering two temporal mechanisms driving breakthrough viral infections after vaccination.
    Vaccine. 2025;63:127638.
    PubMed         Abstract available
    
    
57. YOU D, Quan J, Bishai D, Lam WWT, et al
    Evaluating cost-effectiveness of 9-valent HPV vaccination for men who have sex with men by HIV status in Hong Kong.
    Vaccine. 2025;63:127625.
    PubMed         Abstract available
    
    
58. TSCHERNE A, Sun W, Liu STH, Krammer F, et al
    Mucosal COVID-19 vaccines in clinical development.
    Vaccine. 2025;63:127602.
    PubMed         Abstract available
    
    
59. MACDONALD NE, Dube E, Graham JE
    Political vaccine hesitancy: not new but growing problem.
    Vaccine. 2025;63:127643.
    PubMed        
    
    
60. LUONG NGUYEN LB, Magloire L, Francois A, Billard D, et al
    Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART study.
    Vaccine. 2025;63:127633.
    PubMed         Abstract available
    
    
61. EDAO B, Upadhyay I, Zhang W
    Effect of 5 % lactose and 0.1 % polysorbate 80 buffer on protein-based multivalent ETEC vaccine candidate MecVax stabilization and immunogenicity.
    Vaccine. 2025;63:127634.
    PubMed         Abstract available
    
    
62. CHAN MXJ, Khoo YK, Stona AC, Joarder T, et al
    Regulatory factors affecting sustainable vaccine manufacturing in Asia and the Pacific: Findings from a scoping review and semi-structured interviews.
    Vaccine. 2025;63:127607.
    PubMed         Abstract available
    
    
63. ITO T, Yamaji Y, Sawada A, Nakayama T, et al
    Evaluation of immunogenicity of mumps vaccine strains in cotton rat (Sigmodon hispidus) model.
    Vaccine. 2025;63:127640.
    PubMed         Abstract available
    
    
64. ZHANG X, Zhang X, Lu J, Yang P, et al
    The mRNA vaccine encoding Gc protein confers complete protection against severe fever with thrombocytopaenia syndrome virus.
    Vaccine. 2025;63:127631.
    PubMed         Abstract available
    
    
65. LLOYD PC, Acharya G, Zhao H, Chen B, et al
    Safety monitoring of health outcomes following influenza vaccination during the 2023-2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series analyses.
    Vaccine. 2025;63:127614.
    PubMed         Abstract available
    
    
66. CHUVILEVA YE, Kuiper NM, Ramakrishnan A, Goodman K, et al
    Weaving a public health network: Process and results from an evaluation of CDC's Prevention Research Centers Vaccine Confidence Network.
    Vaccine. 2025;60 Suppl 1:127636.
    PubMed         Abstract available
    
    
67. SHAW CA, Stewart-Jones GBE, Jorquera P, Narayanan E, et al
    Design and preclinical assessment of mRNA-1345 prefusion F glycoprotein-encoding mRNA vaccine for respiratory syncytial virus.
    Vaccine. 2025;63:127589.
    PubMed         Abstract available
    
    
68. CAI H, Jia B, Song Z, Wang L, et al
    Real-world safety of herpes zoster vaccines: A pharmacovigilance study based on the vaccine adverse event reporting system (may 2006-december 2024).
    Vaccine. 2025;63:127628.
    PubMed         Abstract available
    
    
69. KARRAS J, Harrison M, Danchin M, Kaufman J, et al
    Supporting dialogue amongst multicultural communities: Exploring the role of vaccine champions.
    Vaccine. 2025;63:127629.
    PubMed         Abstract available
    
    

    
    Virology

70. ZENG F, Liu Q, Wang X, Zhong P, et al
    Immunoinformatics design and experimental expression of a multi-epitope vaccine simultaneously targeting AAV2 and HAdV-F41 against acute hepatitis of unknown etiology.
    Virology. 2025;611:110653.
    PubMed         Abstract available
    
    
71. ZHANG S, Liu G, Guo A, Chen Y, et al
    Maternal antibody transfer efficiency: The impact of M. bovis-BoHV-1 combined vaccine.
    Virology. 2025;611:110656.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.